(-)- Epigallocatechin-3-gallate induces GRP78 accumulation in the ER and shifts mesothelioma constitutive UPR into proapoptotic ER stress
- PMID: 29744892
- DOI: 10.1002/jcp.26631
(-)- Epigallocatechin-3-gallate induces GRP78 accumulation in the ER and shifts mesothelioma constitutive UPR into proapoptotic ER stress
Abstract
GRP78 is a molecular chaperone of the endoplasmic reticulum (ER) that aids proper folding of nascent polypeptides. When unfolded proteins accumulate, GRP78 triggers unfolded protein response (UPR), involving activation of transcription factors like XBP1 and CHOP that may restore cell homeostasis. Increased expression of GRP78 and mild UPR can be constitutive in cancer cells, hindering apoptosis, and promoting cell survival, for example, by GRP78 relocation to the plasma membrane that activates MAPK and PI3 K/AKT pathways. These processes are thought to favor the insurgence of chemoresistance and worsen patient outcome. We have previously shown that (-)-epigallocatechin-3-gallate (EGCG) enhances ROS production and alters Ca2+ homeostasis in cell lines deriving from therapy-recalcitrant malignant mesothelioma (MMe). We consider here the EGCG impact on GRP78 and downstream factors by using qRT-PCR, Western blot, immunofluorescence, caspase assays, GRP78 siRNA silencing, and cell surface ELISA. MMe cells were found to display mild constitutive UPR, as shown by increased levels of GRP78, and presence of the protein at the cell surface, linked to AKT activation. Exposure to EGCG further increased GRP78 in the ER, and induced ATF4, spliced XBP1, CHOP, and EDEM expressions, combined with a reduction of cell surface GRP78 and a rise in caspase 3 and 8 activities. We propose that GRP78 accumulation in the ER, caused by EGCG, converts constitutive UPR of MMe cells into proapoptotic ER stress. This argues for a possible therapeutic use of EGCG in the treatment of MMe as a co-drug able to abolish chemoresistance to conventional drugs at tolerable doses.
Keywords: ATF4; CHOP/GADD 153; XBP1; endoplasmic reticulum stress; unfolded protein response.
© 2018 Wiley Periodicals, Inc.
Similar articles
-
Endoplasmic Reticulum Stress and Cancer: Could Unfolded Protein Response Be a Druggable Target for Cancer Therapy?Int J Mol Sci. 2023 Jan 13;24(2):1566. doi: 10.3390/ijms24021566. Int J Mol Sci. 2023. PMID: 36675080 Free PMC article. Review.
-
Insights on the involvement of (-)-epigallocatechin gallate in ER stress-mediated apoptosis in age-related macular degeneration.Apoptosis. 2017 Jan;22(1):72-85. doi: 10.1007/s10495-016-1318-2. Apoptosis. 2017. PMID: 27778132
-
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.Cancer Res. 2007 Oct 15;67(20):9809-16. doi: 10.1158/0008-5472.CAN-07-0625. Cancer Res. 2007. PMID: 17942911
-
The 78-kD Glucose-Regulated Protein Regulates Endoplasmic Reticulum Homeostasis and Distal Epithelial Cell Survival during Lung Development.Am J Respir Cell Mol Biol. 2016 Jul;55(1):135-49. doi: 10.1165/rcmb.2015-0327OC. Am J Respir Cell Mol Biol. 2016. PMID: 26816051 Free PMC article.
-
GRP78 in lung cancer.J Transl Med. 2021 Mar 21;19(1):118. doi: 10.1186/s12967-021-02786-6. J Transl Med. 2021. PMID: 33743739 Free PMC article. Review.
Cited by
-
Endoplasmic Reticulum Stress and Cancer: Could Unfolded Protein Response Be a Druggable Target for Cancer Therapy?Int J Mol Sci. 2023 Jan 13;24(2):1566. doi: 10.3390/ijms24021566. Int J Mol Sci. 2023. PMID: 36675080 Free PMC article. Review.
-
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.Chin Med. 2019 Nov 6;14:48. doi: 10.1186/s13020-019-0270-9. eCollection 2019. Chin Med. 2019. PMID: 31719837 Free PMC article. Review.
-
The Role of Epigallocatechin-3-Gallate in Autophagy and Endoplasmic Reticulum Stress (ERS)-Induced Apoptosis of Human Diseases.Med Sci Monit. 2020 Sep 10;26:e924558. doi: 10.12659/MSM.924558. Med Sci Monit. 2020. PMID: 32952149 Free PMC article. Review.
-
ER Stress Response and Induction of Apoptosis in Malignant Pleural Mesothelioma: The Achilles Heel Targeted by the Anticancer Ruthenium Drug BOLD-100.Cancers (Basel). 2022 Aug 26;14(17):4126. doi: 10.3390/cancers14174126. Cancers (Basel). 2022. PMID: 36077664 Free PMC article.
-
Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.Cancer Sci. 2019 Feb;110(2):582-595. doi: 10.1111/cas.13900. Epub 2019 Jan 2. Cancer Sci. 2019. PMID: 30520540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous